Zika virus: what, where from and where to?

Pathology. 2017 Dec;49(7):698-706. doi: 10.1016/j.pathol.2017.08.002. Epub 2017 Oct 16.

Abstract

The significance of Zika virus as a clinically significant flavivirus has previously been under-recognised, until extensive outbreaks in Yap in 2007, French Polynesia in 2013 and the Americas since 2015. Although Zika virus infection is commonly asymptomatic or mild, emerging evidence suggests a strong link to microcephaly in babies and Guillain-Barré syndrome in adults. This article reviews the epidemiology, geographic distribution, basic virology, transmission, clinical presentation, potential complications, laboratory diagnosis, treatment and prevention of Zika virus infection. Education on mosquito avoidance measures and vector control efforts currently remain key to reducing risk of transmission, whilst further research is underway to develop antiviral therapies and vaccines.

Keywords: Aedes; Guillain–Barré syndrome; Zika virus; flavivirus; microcephaly.

Publication types

  • Review

MeSH terms

  • Adult
  • Animals
  • Antiviral Agents / therapeutic use*
  • Culicidae / virology*
  • Guillain-Barre Syndrome / virology
  • Humans
  • Infant
  • Insect Vectors / virology*
  • Microcephaly / virology
  • Mosquito Control*
  • Zika Virus / physiology*
  • Zika Virus Infection / drug therapy
  • Zika Virus Infection / epidemiology
  • Zika Virus Infection / transmission
  • Zika Virus Infection / virology*

Substances

  • Antiviral Agents